麻疹病例的流行病学,以及Tecovirimat和JYNNEOS利用,加利福尼亚州阿拉梅达县,2022年6月至10月
Megan L Ouyang1, Rachel Marusinec, Paul J Bayard
1Division of Communicable Disease Control and Prevention, Alameda County Public Health Department, San Leandro, California (Drs Ouyang, Trivedi, Yette, Dunne, and Chitnis, Mss Marusinec, Peña, Shemsu, and Sheppard, and Messrs Johnson, Menker, and Moore); Alameda County Health Care Services Agency, San Leandro, California (Dr Moss); Office of Public Health Director, Alameda County Public Health Department, San Leandro, California (Dr Ayala); La Clínica de La Raza, Oakland, California (Dr Bayard); LifeLong Medical Care, Oakland, California (Dr Edmunds); Alameda Health System, Oakland, California (Dr Lai); Asian Health Services, Oakland, California (Dr Nguyen); Kaiser Permanente Medical Center, Oakland, California (Dr Rajagopal); Bay Area Community Health, Fremont, California (Dr Slome); and East Bay Advanced Care, Alta Bates Summit Medical Center, Sutter Health, Oakland, California (Dr Tang).George Ayala and Amit Chitnis are senior co-authors.Current affiliation of Dr Megan Ouyang is County of Santa Clara Public Health Department, San Jose, California.Current affiliation of Ms April Peña is San Francisco Department of Public Health, San Francisco, California.
莫波克斯在阿拉米达县不成比例地影响了与男性发生性关系的黑人和西班牙裔男性. 虽然mopox治疗 (TPOXX) 可以获得,但JYNNEOS疫苗的接种需要通过社区参与来改善.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 传染病监测 传染病监测 传染病
背景情况:
- 2022年美国mopox疫情突出显示了严重的健康差异.
- 种族和民族少数群体的同性恋,双性恋和其他与男性发生性关系的男性受到了不成比例的影响.
研究的目的:
- 评估阿拉梅达县受影响人口中的mpox (麻疹) 治疗和JYNNEOS疫苗分配.
- 评估2022年mopox流行期间公共卫生干预措施的有效性.
主要方法:
- 利用了阿拉米达县的监测数据和疫苗注射登记册 (2022年6月1日至10月31日).
- 根据种族/种族和性取向分析了mopox发病率.
- 在mopox病例和与男性发生性关系的男性中检查了接受tecovirimat (TPOXX) 和JYNNEOS疫苗的情况.
主要成果:
- 黑人/非洲裔美国人 (35.7/100k) 和西班牙裔/拉丁裔 (25.1/100k) 居民中,mpokx发病率最高.
- 同性恋,双性恋和其他与男性发生性关系的男性占mpox病例的大多数 (82.9%).
- 每10万与男性发生性关系的男性接种疫苗率在亚洲人和西班牙裔/拉丁裔人群中最低,黑人/非裔美国人和西班牙裔/拉丁裔男性的接种疫苗率较低.
结论:
- 在阿拉米达县,Mpox不成比例地影响了与男性发生性关系的黑人/非裔美国人和西班牙裔/拉丁裔男性.
- 合作伙伴关系促进了mpox患者获得TPOXX治疗的机会.
- 加强社区参与对于改善黑人和拉丁裔LGBTQ+社区的JYNNEOS疫苗接种至关重要.
相关概念视频
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Sexually Transmitted Infections
Clinical Trials
There are four phases in a clinical trial. A phase one...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...


